Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a randomized controlled trial

In postmenopausal women, 2-years of combined teriparatide and denosumab increases bone mineral density (BMD) more than either drug alone and switching from either combination or teriparatide to denosumab for an additional 2-years further increases BMD. Conversely switching from denosumab to teripara...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Densitom
Main Authors: Tsai, JN, Jiang, LA, Lee, H, Hans, D, Leder, BZ
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673584/
https://ncbi.nlm.nih.gov/pubmed/28624340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocd.2017.05.007
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items